Skip to main content
L

Lunaphore

Swiss life sciences company founded in 2014, developing microfluidic chip technology and the COMET™ platform for multiplex spatial proteomics and transcriptomics in tissue analysis.

Lunaphore is a Swiss life sciences company founded in 2014 that develops microfluidic chip technology to extract spatial proteomic and transcriptomic data from tumours and other tissues. The technology converts simple assays into multiplex spatial biology without added complexity, supporting work in immuno-oncology, neuroscience, immunology and translational research toward personalised therapies. The company is part of Bio-Techne's Spatial Biology Division and collaborates with ACD's RNAscope™ technology to deliver integrated multiomics solutions. Its principal product, COMET™, is a fully automated, high-throughput spatial biology platform spanning the workflow from assay development to cohort analysis in a matter of weeks. The system works with off-the-shelf, label-free primary antibodies rather than proprietary formulations, a design choice that keeps assays flexible for individual laboratories. The stated mission is to make spatial biology accessible to every laboratory. Much of the team comes from research and academic backgrounds, with firsthand experience of the limitations of traditional tissue analysis, and the company's culture is oriented towards accelerating scientific discovery. Lunaphore operates from Switzerland.

Open jobs

No open jobs right now.